A New Leash on Life for Modern Dogs

As society shifts toward urban living, dogs are undergoing a new wave of domestication, adapting to our modern lifestyles. Historically valued for their work ethic and protective instincts, today’s pets are expected to be calm, friendly, and adaptable companions. Service dogs exemplify this transformation, showcasing friendliness and social bonding traits that reflect early domestication patterns. These dogs offer a blueprint for a new type of pet, where temperament, not just appearance, becomes the breeding focus. This shift promises to reshape the future of our beloved canine companions. Dogs Are Entering a New Wave of Domestication - The Atlantic.

Nourishing Medical Minds

A panel of experts has urged medical schools to integrate comprehensive nutrition education into their curricula, citing diet as a significant factor in seven of the ten leading causes of death in the U.S. In a new consensus statement published in JAMA Network Open, the panel outlined 36 key nutrition competencies for medical training. Despite the undeniable link between diet and health, most medical programs offer little to no instruction on nutrition. The panel emphasizes that improving doctors’ understanding of nutrition can greatly enhance patient care and disease prevention strategies. Panel recommends medical nutrition training, citing diet disease risks - The Washington Post (gift article).

Bot or Not

Generative AI platforms like Character.AI enable users to create chatbots impersonating real people, often without their consent, leading to ethical dilemmas. A notable case involves the unauthorized creation of a bot modeled after Jennifer Ann Crecente, a teen murdered in 2006. Her father, Drew Crecente, discovered this AI bot mimicking his daughter’s identity, bringing fresh grief. Despite Character.AI’s policies, countless non-consensual bots remain. Legal protections lag, leaving those impersonated with little recourse as the line between digital personas and personal privacy blurs in this rapidly evolving space. Anyone Can Turn You Into an AI Chatbot. There’s Little You Can Do to Stop Them | WIRED.

Metformin’s Miss

Metformin, a widely used diabetes drug, once sparked hopes of being a cancer-fighting breakthrough. Early studies suggested that the drug could reduce cancer risk and enhance chemotherapy effects, but subsequent large-scale trials failed to confirm these benefits. Researchers now attribute earlier positive findings to flaws like “immortal time bias” and excessively high doses used in lab studies. While metformin remains promising for other conditions like aging and dementia, its potential as a cancer treatment has been largely dismissed, with experts calling for more cautious optimism. This Common Diabetes Drug Was Thought to Revolutionize Cancer — Here’s What Happened Instead.

Peptide Promises

‘GLP-1’ Has Become an Empty Buzzword - The Atlantic delves into the growing trend of “GLP-1” supplements, marketed as alternatives to weight-loss drugs like Ozempic. Despite their catchy association with GLP-1 agonists, these supplements pale in comparison to the actual effectiveness of obesity drugs. While the natural hormone GLP-1 is released after eating and influences satiety, the supplements only offer a minor boost in GLP-1 levels. Their marketing preys on consumers seeking a cheaper, non-pharmaceutical solution, but in reality, they repurpose common ingredients, leaving people with little more than hollow promises.

Rethinking Obesity

A Gen X physician reflects on his earlier misconceptions about obesity, realizing that it is a complex, mostly neurological, and inheritable disease rather than simply a result of laziness or poor choices. He acknowledges how his success with weight loss led to a condescending attitude toward patients who struggled, failing to recognize their unique genetic predispositions. With the introduction of GLP-1 drugs like Ozempic and Wegovy, the doctor is cautiously optimistic that science can finally offer effective treatments for obesity, moving beyond outdated assumptions about personal responsibility. I was once condescending to obese patients. I regret it. - The Washington Post (gift article).

Ozempic Tackles More Than Just Weight

Recent studies reveal that Ozempic, widely known for treating type 2 diabetes and aiding weight loss, might also reduce addiction-related behaviors. Researchers from Loyola University found that those on the drug had significantly lower rates of opioid overdose (40%) and alcohol intoxication (50%) compared to non-users. The findings, derived from analyzing over a million health records, suggest that GLP-1 receptor agonists may influence addiction, though the exact mechanisms remain unclear. While promising, further research is needed to confirm the drug’s potential in addiction treatment. Ozempic Might Help Treat Two Common Addiction Disorders.

People-Pleaser Predicament

How to Stop Being a People Pleaser - The New York Times (gift article) delves into the common habit of people-pleasing, where individuals prioritize others’ needs at the expense of their own. Experts explain how this behavior often stems from childhood or social anxiety and initially offers satisfaction by gaining approval. However, it can lead to resentment and emotional burnout. The article offers practical tips to set boundaries, manage pushback, and overcome fears of rejection. The focus is on building self-worth, prioritizing personal needs, and embracing balance in relationships to prevent feeling drained by constant people-pleasing.

A Playbook for the Heart

Seven Ways to Love Better - The New York Times (gift article) by Daniel Jones, editor of the Modern Love column, reflects on two decades of curating stories about love. He distills seven essential lessons learned from thousands of submissions. Love, he argues, thrives on curiosity, empathy, and impermanence. Relationships should be handled like basketballs, and they should be able to bounce back from conflict. Success is not measured by longevity but by impact. Whether it’s appreciating fleeting moments or navigating difficult separations, Jones emphasizes the importance of being present, open-minded, and grateful for every connection, no matter how brief.

Metformin and Long Covid

A recent study published in The Lancet Infectious Diseases reveals that metformin, a commonly used diabetes drug, may reduce the risk of developing long COVID by 41 percent for individuals who are overweight or have obesity. Long COVID, a condition characterized by persistent symptoms after a COVID-19 infection, has no approved treatment. The study's findings offer hope, but further research is needed to validate the results and explore how metformin prevents long COVID. Although the mechanism is unclear, unlike the authors, who opine that metformin may interfere with viral replication, I think a more likely explanation is that it modulates the immune system through its influence on the microbiome. A Common Diabetes Drug May Prevent Long COVID in Some People - Scientific American

Covid and the Introversion - Extroversion Dynamic

An interesting piece in WaPo about how Covid (permanently?) flipped the script in social dynamics: Opinion | The world has become more introverted. And I hate it. - The Washington Post (gift article)

How to Age Gracefully

A new study suggests that learning new skills can have significant cognitive benefits for older adults. The authors hypothesize that cognitive slowing as a senior is akin to the "summer slide" that schoolchildren experience (every year, teachers and parents observe how summer vacations lead some children's academic progress to backslide). What if the elderly experience a similar phenomenon? The research found that a three-month intervention program involving classes on various skills, such as singing, drawing, and language learning, improved participants' memory and attention. Surprisingly, the cognitive gains continued even after the program ended, with participants' abilities resembling those of individuals 30 years younger. Encouraging lifelong learning and creating enriched environments for older adults could enhance their cognitive skills and support healthy aging. To Stay Sharp as You Age, Learn New Skills - Scientific American

Consciousness Conundrum: Animal Awareness and Neural Correlates

Here is another story from the 26th meeting of the Association for the Scientific Study of Consciousness (mentioned last week). The article discusses the potential consciousness of vertebrates, cephalopods, and arthropods, with debates on their complex behaviors and brain structures. Additionally, the possibility of achieving conscious artificial intelligence and its ethical concerns were discussed. Thousands of species of animals probably have consciousness

How Susceptible are you to Misinformation?

A new test designed to measure susceptibility to misinformation reveals that younger Americans struggle more with identifying fake news than older generations. Researchers developed the "misinformation susceptibility test" (MIST) at the University of Cambridge in collaboration with YouGov. Participants were presented with authentic and AI-generated false headlines and had to differentiate between them. The study found that individuals who spent more time online and relied on social media platforms for news were more prone to falling for misinformation. Age and personality traits also played a role in susceptibility. While the test has some limitations, it underscores the importance of media literacy in navigating the information landscape. How Susceptible Are You to Misinformation? There's a Test You Can Take - Scientific American

Can Math and Physics Save an Arrhythmic Heart?

"Abnormal waves of electrical activity can cause a heart's muscle cells to beat out of sync."_ In Can Math and Physics Save an Arrhythmic Heart?, Flavio Fenton, an expert in cardiac dynamics, discusses ways to treat heart arrhythmias without resorting to painful defibrillators.

Weighing In: The Hidden Costs of Dieting

In the article Why You Don't Just Lose Fat When You're on a Diet Adam Collins explores the consequences of dieting beyond fat loss. While being in a calorie deficit helps shed weight, it also results in the loss of muscle mass. The depletion of glycogen stores leads to the release of water weight. Moreover, the body turns to metabolizing muscle tissue for energy, impacting metabolism and potentially causing weight regain. The article emphasizes the importance of exercise, protein intake, and sustainable lifestyle changes for maintaining muscle mass and preventing metabolic shifts during weight loss.

Ozempic: A Treatment for Addictive Behaviors?

This week, Scientific American published an article on a phenomenon I first mentioned in Newsletter 43. A surprising side effect of Ozempic, a diabetes drug that aids weight loss, has emerged: users report a reduction in cravings for addictive substances such as nicotine, alcohol, and gambling. Scientists are now investigating whether these weight-loss drugs, including Ozempic, can be used to treat addiction. Ozempic targets a hormone that regulates appetite and weakens the brain's Association between food and pleasure. Animal studies have shown promising results, but human trials are still limited. Researchers are initiating their studies to determine the safety and effectiveness of these drugs in addiction treatment. Could New Weight-Loss Drugs like Ozempic Treat Addiction? - Scientific American (Thanks Dave Pell, NextDraft)

The Epidemic of Loneliness

"Research has shown that a lonely brain is transformed. Neurotransmitters important for bonding and social connection go haywire. The hypothalamic-pituitary-adrenal axis, responsible for modulating stress, is hyperactive. The amygdala, which triggers our fight-or-flight response and helps process emotional reactions, is in overdrive: In previous studies, Dr. Cacioppo found that lonely people detect negative or threatening pictures and words in under 400 milliseconds. The neuroscience might explain the sadness that accompanies loneliness and the palpable sense of danger." The New York Times had an insightful piece on loneliness: Opinion | How to Treat Loneliness With Medicine. (gift article)

Psychedelics in the U.S. Defense Funding Bill

Lawmakers included funding in the National Defense Authorization Act to look at psychedelics' role in treating PTSD, depression, anxiety, and chronic pain. Psychedelics like MDMA play a part in US defense funding bill